Startseite>>Lipids>> Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids>>(±)11(12)-DiHET-d11

(±)11(12)-DiHET-d11 (Synonyms: (±)11(12)-DHET-d11, (±)11,12-DiHETrE-d11)

Katalog-Nr.GC46252

A neuropeptide with diverse biological activities

Products are for research use only. Not for human use. We do not sell to patients.

(±)11(12)-DiHET-d11 Chemische Struktur

Cas No.: N/A

Größe Preis Lagerbestand Menge
25 μg
253,00 $
Auf Lager
50 μg
482,00 $
Auf Lager
100 μg
914,00 $
Auf Lager
250 μg
2.028,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(±)11(12)-DiHET-d11 contains 11 deuterium atoms at the 16, 16, 17, 17, 18, 18, 19, 19, 20, 20, and 20 positions. It is intended for use as an internal standard for the quantification of (±)11(12)-DiHET by GC- or LC-mass spectrometry. Epoxide hydrolases convert the EETs into vicinal diols, with the concurrent loss of much of their biological activity.1 (±)11(12)-DiHET relaxes U-46619 -contracted artery rings with approximately 70% of the magnitude of (±)11(12)-EET .2

1.Oliw, E.H., Guengerich, F.P., and Oates, J.A.Oxygenation of arachidonic acid by hepatic monooxygenases. Isolation and metabolism of four epoxide intermediatesJ. Biol. Chem.257(7)3771-3781(1982) 2.Fang, X., Kaduce, T.L., Weintraub, N.L., et al.Functional implications of a newly characterized pathway of 11,12-epoxyeicosatrienoic acid metabolism in arterial smooth muscleCirculation Research79784-793(1996)

Bewertungen

Review for (±)11(12)-DiHET-d11

Average Rating: 5 ★★★★★ (Based on Reviews and 10 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (±)11(12)-DiHET-d11

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.